Chloe Ayres
Chloe Ayres has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Cathy van de Graaf
University Medical Center Groningen Groningen The Netherlands
1 shared publication- Elizabeth Nathan
Department of Biostatistics, Women and Infants Research Foundation, KEM Hospital for Women, Perth, Australia
1 shared publication - Emma Rose Allanson
Division of Obstetrics and Gynaecology, The University of Western Australia—Perth Campus, Perth, Western Australia, Australia
1 shared publication - Erin Kelty
Perth Western Australia 6009 The University of Western Australia School of Population and Global Health
1 shared publication - Fieke Teertstra
University Medical Center Groningen Groningen The Netherlands
1 shared publication - Ganendra Raj Mohan
Department of Obstetrics and Gynaecology, King Edward Memorial Hospital Women's and Newborns Health Service Perth Australia
1 shared publication
Latest Publications
- 18 November 2026
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 66 (6)
Patterns of Care in Patients With Cervical Cancer in Western Australia: A Retrospective Cohort Study
Background: Cervical cancer is an important public health concern with underserved populations having higher incidence and mortality. Aims: To examine associations between patient and tumour characteristics, receipt of appropriate treatment and survival. Materials and Methods: Retrospective cohort study of cervical cancer patients managed by the Western Australian Gynaecological Cancer Service from 1 January 2009 to 31 December 2018. Appropriate treatment was defined by international guidelines. Univariable and multivariable analyses assessed associations between demographic and tumour factors and receipt of appropriate treatment. Survival outcomes were evaluated using multivariable Cox regression. Results: Of 526 patients included, 95.4% received treatment, of which 94.4% received appropriate treatment. Non‐English‐speaking patients had reduced odds of completing treatment (OR 0.28, 95% CI 0.10–0.80, p = 0.018), and patients of lower socioeconomic status had reduced odds of timely treatment (OR 0.57, 95% CI 0.35–0.93, p = 0.025). Patients aged over 60 years had lower odds of receiving any, complete and timely treatment. Those diagnosed between 2014 and 2018, versus 2009–2013 had increased odds of completing treatment (OR 3.08, 95% CI 1.45–6.45, p = 0.003). Higher disease stage was associated with lower odds of receiving and completing treatment. Overall‐ and disease‐free survival were poorer among patients aged over 60, those with advanced‐stage disease, those diagnosed in 2009–2013, and those who received incomplete treatment or no treatment. Conclusions: Most patients received appropriate treatment. Non‐English‐speaking patients, older patients, and those of low socioeconomic status were less likely to receive appropriate care. Older age, advanced disease stage, diagnosis in 2009–2013, and incomplete treatment were associated with poorer survival.
- 18 November 2026
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 66 (6)
Patterns of Care in Patients With Cervical Cancer in Western Australia: A Retrospective Cohort Study
Background: Cervical cancer is an important public health concern with underserved populations having higher incidence and mortality. Aims: To examine associations between patient and tumour characteristics, receipt of appropriate treatment and survival. Materials and Methods: Retrospective cohort study of cervical cancer patients managed by the Western Australian Gynaecological Cancer Service from 1 January 2009 to 31 December 2018. Appropriate treatment was defined by international guidelines. Univariable and multivariable analyses assessed associations between demographic and tumour factors and receipt of appropriate treatment. Survival outcomes were evaluated using multivariable Cox regression. Results: Of 526 patients included, 95.4% received treatment, of which 94.4% received appropriate treatment. Non‐English‐speaking patients had reduced odds of completing treatment (OR 0.28, 95% CI 0.10–0.80, p = 0.018), and patients of lower socioeconomic status had reduced odds of timely treatment (OR 0.57, 95% CI 0.35–0.93, p = 0.025). Patients aged over 60 years had lower odds of receiving any, complete and timely treatment. Those diagnosed between 2014 and 2018, versus 2009–2013 had increased odds of completing treatment (OR 3.08, 95% CI 1.45–6.45, p = 0.003). Higher disease stage was associated with lower odds of receiving and completing treatment. Overall‐ and disease‐free survival were poorer among patients aged over 60, those with advanced‐stage disease, those diagnosed in 2009–2013, and those who received incomplete treatment or no treatment. Conclusions: Most patients received appropriate treatment. Non‐English‐speaking patients, older patients, and those of low socioeconomic status were less likely to receive appropriate care. Older age, advanced disease stage, diagnosis in 2009–2013, and incomplete treatment were associated with poorer survival.